Mankind Pharma Ltd shares surged nearly 3% after acquiring the Rivotril brand from Roche for the Indian market, strengthening its presence in CNS therapies. The stock rose to ₹2,125.10.
Mankind Pharma Ltd shares surged nearly 3% after acquiring the Rivotril brand from Roche for the Indian market, strengthening its presence in CNS therapies. The stock rose to ₹2,125.10.